Navigation Links
Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
Date:9/7/2011

Glycemic Control Independently of Diabetes Duration and Insulin Resistance in Patients with Type 2 Diabetes

Poster

832-P

S Patel, S-A Weber, A Emser,
M von Eynatten, H-J Woerle

Date: Tues, Sept. 13

Time: 1:30−2:30 p.m.Phase II (12-week)Efficacy and Safety of 5 mg Daily Dosing Regimens with Linagliptin in Patients with Type 2 Diabetes Inadequately Controlled on Metformin

Poster

831-P

E Rafeiro, S Ross, T Meinicke, R Toorawa, H-J Woerle

Date: Tues, Sept. 13

Time: 1:30−2:30 p.m.PreclinicalEffect of Linagliptin on Infarction Size and Cardiac Function in Rats After Myocardial Ischaemia Reperfusion

Poster

811-P

T Pfab, Y Sharkovska, M Alter, K von Websky, M Mark, T Klein, B Hocher

Date: Thurs, Sept. 15

Time: 1:30−2:30 p.m.Phase III (104 week)Long-term Efficacy and Safety of the DPP-4 Inhibitor Linagliptin: Data from a Large Two-year Study in Patients with Type 2 Diabetes Mellitus

Oral Presentation

242-OP

A Schlosser, D Owens, M-R Taskinen, S Del Prato, R Gomis, S Patel, A Pivovarova, H-J Woerle

Date: Fri, Sept. 16

Time: 11:45 a.m.−12:00 p.m.Empagliflozin DataTitleFormat Authors Date/Time Phase II (12 week) ENCORE: Efficacy and Safety of BI-10773, a new Sodium Glucose Co-transporter-2 (SGLT-2) Inhibitor, in Type 2 Diabetes Patients Inadequately Controlled on Metformin

Oral Presentation

147-OP

L Seman, J Rosenstock, A Jelaska, S Pinnetti, S Hantel, H-J Woerle

Date: Thurs, Sept. 15

Time: 11:15−11:30 a.m.*All times in Western European Summer Time (WEST)Indication and Important Limitations of UseTRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

TRADJENTA should not be used in patients with type 1 diabetes or for the treatment of diabetic ke
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014  Alere Inc. (NYSE: ... diagnostic tests, has appointed Juliet Cunningham as ... Cunningham will be responsible for driving communications with the ... on a series of changes to increase shareholder value, ... to investors," said Namal Nawana, Chief Executive Officer. "We ...
(Date:11/21/2014)... CLEMENTE, Calif. , Nov. 21, 2014 ... Coats and Performance Scrubs carried out a new product ... medical industry,s very first "limited edition" lab coat ... first female professors of surgery in the world. The ... from its unisex predecessors, with a sleek envelope collar, ...
(Date:11/21/2014)... 21, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... consumables for the medical, research, and veterinary markets worldwide ... research markets in the United States ... agreement to acquire 100% of QCR & Trio Diagnostics ... distribution organization. The transaction closed on November 17, 2014. ...
Breaking Medicine Technology:Alere Appoints Juliet Cunningham to Lead Investor Relations 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4
... 16, 2007 - Amgen,(Nasdaq:AMGN) today presented the results ... the,efficacy and safety of Aranesp(R) (darbepoetin alfa) for ... not receiving,chemotherapy or radiotherapy ("the 103 study"). Aranesp ... EMEA in these patients. These,results were presented in ...
... WIRE)--Apr 16, 2007 - Arsenic, a naturally,occurring element, ... years, and even now remains a venerable constituent ... to the efforts of investigators supported,by grants from ... Walls," an arsenic derivative is being,utilized in therapy ...
Cached Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 2Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 3
(Date:11/24/2014)... 2014 Dr. Michael Kettel , a ... appeared on NBC to discuss egg freezing as a viable ... trending in the news recently, with new company benefits at ... , “[The companies] see it as a way ... career hot path.” Says Dr. Kettel. , Up until a ...
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has unveiled its new ... are now offered at deeply discounted prices, up to 75 ... Dec. 15. The main purpose of the promotion is to ... items are ideal options for ladies who are eager to ... its new mint cocktail dresses are very beautiful; they are ...
(Date:11/23/2014)... 24, 2014 Tbdress.com has recently ... online on Nov. 28, 2014. The special offer will provide ... Tbdress.com is one of the world’s largest women’s dresses retailers, ... colors. People can enjoy great discounts on that day: Everything ... free delivery (for orders above $89). , People can use ...
(Date:11/23/2014)... 21, 2014 (HealthDay News) -- Close friends have more ... group does, a new study says. "We,ve ... have an influence on individual alcohol use, but there ... peer group and the friend group,s influence on those ... School of Public Health, said in a university news ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 This ... such as its significance, programs and manufacturing technological ... Chinese suppliers major market gamers in information. In ... item specifications, prospective, manufacturing value, and 2009-2014 market ... the evaluation symbolizes the globally and Chinese suppliers ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Close Friends May Be Key to Teens' Drinking 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4
... Sept. 11 Bupa,s Latin America and Caribbean,operation -- ... --,announced today the launch of the international Ecuador Challenge, ... where many families survive on,average on just $4 a ... will,travel to Ecuador until November 29 to build essential ...
... FRANKLIN, Mass., Sept. 11 PLC Systems Inc. ... cardiac and vascular medical device-based technologies, today provided an ... the annual meeting of the European Society of Cardiology, ... More than 30,000 clinicians and professionals attended this ...
... , Flu Clinic Locator Available on ... Seasonal Flu Vaccination Clinics and Stay Healthy , , ... easier for people to get their seasonal flu vaccine this year with ... of public seasonal influenza vaccination clinics is now available at ...
... , , LIBERTYVILLE, Ill., Sept. ... believed to be exterminated nationwide, the teeny, insidious bloodsuckers--which feast on ... , They,re being spotted in hotels from coast to ... and upscale chains. In a recent study of 700 mid-priced hotels, ...
... death rates alone doesn,t measure severity of cases, researchers say ... questions the value of hospital report cards and national rankings ... Loyola University Health System in Chicago say the mortality index, ... has in a given area of medical care, may be ...
... , CUPERTINO, Calif., Sept. 11 -- DURECT ... has entered into a privately negotiated transaction to sell 4,444,444 ... a price of $2.25 per share, raising net proceeds to ... to close on or about September 18, 2009, subject to ...
Cached Medicine News:Health News:Bupa Launches its 2009 International Charity Challenge to Help a Rural Community in Ecuador 2Health News:PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009 2Health News:PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009 3Health News:American Lung Association Supports Health Officials to Prevent the Spread of Seasonal Influenza by Urging People to Get Vaccinated 2Health News:American Lung Association Supports Health Officials to Prevent the Spread of Seasonal Influenza by Urging People to Get Vaccinated 3Health News:American Lung Association Supports Health Officials to Prevent the Spread of Seasonal Influenza by Urging People to Get Vaccinated 4Health News:Rest Easy, the Safe, All-Natural Bed Bug Travel Spray 2Health News:Report Cards for Hospitals May Be Misleading 2Health News:DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million 2
... Volu-Sol's New Methylene Blue, ... to use. This stain ... does not require any counter-staining. ... in three different sizes, 30 ...
... in methanol for faster, more complete ... smears. Our special manufacturing process yields ... elements producing unequaled definition of cytoplasmic ... brilliance in the resulting smear. Used ...
... Volu-Sol's Stat Stain is ideal for stat, ... stain blood smears (10-15 seconds) and bone ... generates finely dispersed stain particles which yield ... eliminates many of the steps involved in ...
... single-solution staining, Hema-Quik II for ... into stain solution for five ... deionized water for five to ... time by dipping quickly in ...
Medicine Products: